Anzeige
Mehr »
Sonntag, 22.06.2025 - Börsentäglich über 12.000 News
500 % Kursplus seit Januar. 462 g/t Goldgehalte. Mrd.-Investoren an Bord. Dieser finnische Junior wird heiß!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
132 Leser
Artikel bewerten:
(0)

CompuGroup Medical's CGM LabDAQ Laboratory Information System Receives Quest Diagnostics Quality Solutions Certification

OWINGS MILLS, Md., Jan. 21, 2014 /PRNewswire/ --CompuGroup Medical US announced today that CGM LabDAQ LIS has been certified as a Gold Quality Solution by Quest Diagnostics under Quest's Health IT Quality Solutions' Program (the "Program"). Quest Diagnostics is the world's leading provider of diagnostic information services.

As a certified Health IT Quality Solution, CompuGroup Medical's CGM LabDAQ has been recognized by Quest Diagnostics as meeting or exceeding advanced industry standards for health IT quality and for providing a streamlined, interoperable solution that enables secure clinical laboratory ordering and results reporting through Quest Diagnostics connectivity solutions.

Quest Diagnostics created the Health IT Quality Solutions Program to collaborate with providers of electronic health record (EHR) and other clinical technologies such as CGM LabDAQ to achieve optimized levels of clinical and operational quality for the benefit of physician practices, hospitals, and integrated delivery networks. The Program is designed to maximize data quality, as well as data and business process interoperability between Quest Diagnostics and select clinical technology solutions that meet Quest's high standards.

"We believe that this certification validates our seamless integration with Quest Diagnostics and solidifies our 15 year progressive and growing partnership," said Jim Kasoff, President, CompuGroup Medical, Laboratory Division.

To be eligible for the Program, a clinical technology solution must have an approved and commercially viable interface to Quest Diagnostics web service's Data Exchange Service, which processes both lab orders and results. It can then qualify for one of three certification tiers -- Silver, Gold, or Platinum -- by meeting an increasingly stringent and comprehensive set of criteria related to laboratory order and result functionality, implementation processes, and other mutually-beneficial business activity.

"Certified vendors have clearly demonstrated their commitment to helping healthcare providers use technology at the highest levels of quality and process excellence in order to meet a growing set of challenges relating to information technology, regulatory requirements, and industry demands," said Keith C. Drake, Ph.D., Quality Solutions Program Executive, Quest Diagnostics. "The focus of CompuGroup Medical on quality and lab interoperability validates their leadership in the marketplace." For more information on Quest Diagnostics' Health IT Quality Solutions Program, visit QuestDiagnostics.com/QualitySolutions.

About CompuGroup Medical US

CompuGroup Medical US is the US division of CompuGroup Medical AG, -- one of the leading eHealth companies in the world. CompuGroup Medical US works to synchronize the systems of the healthcare industry with the mission of patient care, enabling providers to achieve the best possible outcomes for their patients. CompuGroup Medical US creates healthcare IT solutions to support the clinical and practice management activities that take place in physician practices, community health centers and hospitals. These solutions include Meaningful Use certified electronic health records (EHRs) that are proven to contribute to safer, higher-quality and more efficient healthcare. We also provide practice management (PM) software and productivity tools, EDI/reimbursement, lab information systems and more. For more information about CompuGroup Medical US, visit www.cgm.com/us.

About CompuGroup Medical AG

CompuGroup Medical AG is one of the leading eHealth companies in the world. Its software products are designed to support all medical and organizational activities in doctors' offices, pharmacies, laboratories and hospitals. Its information services for all parties involved in the healthcare system and its web-based personal health records contribute towards safer and more efficient healthcare. CompuGroup Medical's services are based on a unique customer base of over 400,000 doctors, dentists, hospitals, pharmacies and networks as well as other service providers. With locations in 19 countries and customers in 43 countries worldwide, CompuGroup Medical is the eHealth company with among the highest coverage among eHealth service providers. Approximately 4,000 highly qualified employees support customers with innovative solutions for the steadily growing demands of the healthcare system.

LabDAQ is a registered trademark of CompuGroup Medical, Inc. CGM is a registered trademark of CompuGroup Medical AG.

(Logo: http://photos.prnewswire.com/prnh/20130716/NE48278LOGO)

Contact for media representatives:

CompuGroup Medical US
Kristin Brillantes
Marketing Manager, Laboratory Division
Kristin.brillantes@cgm.com
P: 800.359.0911 x1152
F: 410.517.0331

SOURCE CompuGroup Medical

© 2014 PR Newswire
Zeitenwende! 3 Uranaktien vor der Neubewertung
Ende Mai leitete US-Präsident Donald Trump mit der Unterzeichnung mehrerer Dekrete eine weitreichende Wende in der amerikanischen Energiepolitik ein. Im Fokus: der beschleunigte Ausbau der Kernenergie.

Mit einem umfassenden Maßnahmenpaket sollen Genehmigungsprozesse reformiert, kleinere Reaktoren gefördert und der Anteil von Atomstrom in den USA massiv gesteigert werden. Auslöser ist der explodierende Energiebedarf durch KI-Rechenzentren, der eine stabile, CO₂-arme Grundlastversorgung zwingend notwendig macht.

In unserem kostenlosen Spezialreport erfahren Sie, welche 3 Unternehmen jetzt im Zentrum dieser energiepolitischen Neuausrichtung stehen, und wer vom kommenden Boom der Nuklearindustrie besonders profitieren könnte.

Holen Sie sich den neuesten Report! Verpassen Sie nicht, welche Aktien besonders von der Energiewende in den USA profitieren dürften, und laden Sie sich das Gratis-PDF jetzt kostenlos herunter.

Dieses exklusive Angebot gilt aber nur für kurze Zeit! Daher jetzt downloaden!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.